<DOC>
	<DOCNO>NCT01234181</DOCNO>
	<brief_summary>The purpose study , determine difference clinical outcome hypoxic pre-treatment group control group bone marrow stem cell transplantation ( BM-SCT ) treat acute myocardial infarction ( AMI ) ; evaluate safety treatment . Heart failure patient underwent PCI treatment AMI inform consent , randomize allocation hypoxic pre-treated BM-SCT group , normoxic pre-treated BM-SCT group , control group . Cell resuspension intracoronary inject patient receive coronary angiography , IL-6 , CRP , TNF BNP detect ; echocardiography , cardiac MRI ECT analyze evaluate heart function alive myocardial cell . Holter 's ECG monitor employ observe arrhythmia embolism . We hypothesize , receive hypoxic pre-treated BM-SCT , impaired heart function reverse heart failure patient .</brief_summary>
	<brief_title>Clinical Study Hypoxia-Stressed Bone Marrow Mononuclear Cell Transplantation Treat Heart Diseases</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Clinical diagnosis acute Myocardial Infarction ( within one month ) ; Age 65 ; Infarction relate wall motion abnormality echocardiography ; Infarction relate TIMI flow grade 3 coronary angiography cell injection ; Informed consent ; Active infection , hematopoietic malignancy ; Patients tumor lethal disease ; Informed refusal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>